The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence model for predicting the efficacy of sintilimab plus chemotherapy in treating patients with esophageal squamous cell carcinoma.
 
Kefeng Wang
No Relationships to Disclose
 
Duoguang Wu
No Relationships to Disclose
 
Wenjian Wang
No Relationships to Disclose
 
Kai Lei
No Relationships to Disclose
 
Ruihao Liang
No Relationships to Disclose
 
Binghua Tan
No Relationships to Disclose
 
Xueting Hu
No Relationships to Disclose
 
Lin Li
No Relationships to Disclose
 
Yingcheng Lyu
No Relationships to Disclose
 
Zhizheng Wang
Employment - Origimed
 
Yanwu Zeng
Employment - Origimed
 
Fei Pang
Employment - Origimed
 
Kai Wang
Employment - Origimed
Leadership - Origimed
Stock and Other Ownership Interests - Origimed
 
Huayue Lin
No Relationships to Disclose
 
Minghui Wang
No Relationships to Disclose